NYSE:BMY

Bristol Myers Squibb

Stock

49.61 −1.18%

1.18

USD last updated 27/07 01:51:33

Last Close

48.43

25/07 22:30

Market Cap

83.35B

Beta: 0.43

Volume Today

17.16M

Avg: 7.82M

PE Ratio

11.94

PFCF: 8.37

Dividend Yield

4.80%

Payout:57.08%

Overview Financials API

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

Description

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor...Show More

NYSE:BMY

Bristol Myers Squibb

49.61

−1.18%

1.18

Last Close

48.43

25/07 22:30

Market Cap

83.35B

Beta: 0.43

Volume Today

17.16M

Avg: 7.82M

PE Ratio

11.94

PFCF: 8.37

Dividend Yield

4.80%

Payout:57.08%

This will be loaded shortly.

Loading

This will be loaded shortly.

Loading

This will be loaded shortly.

Loading

Description

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)